Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease

Pediatric Nephrology

Volumn 25, Issue 6, 2010, Pages 1139-1146

  Jia, Guangfu ^a   Kwon, Michelle ^a   Liang, Huan Ling ^a   Mortensen, Jordan ^a   Nilakantan, Vani ^a   Sweeney, William E ^a   Park, Frank ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin converting enzyme; Apoptosis; Autosomal recessive polycystic kidney disease (ARPKD); Cyst; Lisinopril; Proliferation; Western blot

Indexed keywords

BETA ACTIN; CASPASE 3; CASPASE 7; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVITY; KIDNEY COLLECTING TUBULE; KIDNEY POLYCYSTIC DISEASE; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; LISINOPRIL; MALE; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 77951256289     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1477-2     Document Type: Article

References (43)

1. WE Sweeney Jr ED Avner 2006 Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD) Cell Tissue Res 326 671 685 10.1007/s00441-006-0226-0 1:CAS:528:DC%2BD28Xht1entLjM 16767405 (Pubitemid 44786367)
2. LF Onuchic L Furu Y Nagasawa X Hou T Eggermann Z Ren C Bergmann J Senderek E Esquivel R Zeltner S Rudnik-Schoneborn M Mrug W Sweeney ED Avner K Zerres LM Guay-Woodford S Somlo GG Germino 2002 PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats Am J Hum Genet 70 1305 1317 10.1086/340448 1:CAS:528: DC%2BD38XjsFGnsL0%3D 11898128 (Pubitemid 34450580)
3. CJ Ward MC Hogan S Rossetti D Walker T Sneddon X Wang V Kubly JM Cunningham R Bacallao M Ishibashi DS Milliner VE Torres PC Harris 2002 The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein Nat Genet 30 259 269 10.1038/ng833 11919560
4. F Bonnet Z Cao ME Cooper 2001 Apoptosis and angiotensin II: yet another renal regulatory system? Exp Nephrol 9 295 300 10.1159/000052624 1:CAS:528:DC%2BD3MXnt1OrsLg%3D 11549846 (Pubitemid 32830561)
5. A Lautrette S Li R Alili SW Sunnarborg M Burtin DC Lee G Friedlander F Terzi 2005 Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach Nat Med 11 867 874 10.1038/nm1275 1:CAS:528:DC%2BD2MXmvFemsLg%3D 16041383 (Pubitemid 41161119)
6. M Ushio-Fukai RW Alexander M Akers KK Griendling 1998 p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy J Biol Chem 273 15022 15029 10.1074/jbc.273.24.15022 1:CAS:528:DyaK1cXktVeht7k%3D 9614110 (Pubitemid 28272796)
7. JL Zhuo XC Li 2007 Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells J Renin Angiotensin Aldosterone Syst 8 23 33 10.3317/jraas.2007.003 1:CAS:528:DC%2BD2sXmt1emt7g%3D 17487823 (Pubitemid 46779545)
8. AP Balbi HD Francescato EC Marin RS Costa TM Coimbra 2009 Roles of mitogen-activated protein kinases and angiotensin II in renal development Braz J Med Biol Res 42 38 43 10.1590/S0100-879X2009000100007 1:CAS:528: DC%2BD1MXjvV2jsL4%3D 19219295
9. JP Calvet 2008 Strategies to inhibit cyst formation in ADPKD Clin J Am Soc Nephrol 3 1205 1211 10.2215/CJN.05651207 18434615
10. S Kumar J Boehm JC Lee 2003 p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases Nat Rev Drug Discov 2 717 726 10.1038/nrd1177 1:CAS:528:DC%2BD3sXmvVWlsbw%3D 12951578 (Pubitemid 37361787)
11. HJ Schaeffer MJ Weber 1999 Mitogen-activated protein kinases: specific messages from ubiquitous messengers Mol Cell Biol 19 2435 2444 1:CAS:528:DyaK1MXit1amsr4%3D 10082509
12. K Nakanishi WE Sweeney Jr K Macrae Dell CU Cotton ED Avner 2001 Role of CFTR in autosomal recessive polycystic kidney disease J Am Soc Nephrol 12 719 725 1:CAS:528:DC%2BD3MXjtVWgtro%3D 11274233 (Pubitemid 32246700)
13. WG Richards WE Sweeney BK Yoder JE Wilkinson RP Woychik ED Avner 1998 Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease J Clin Invest 101 935 939 10.1172/JCI2071 1:CAS:528:DyaK1cXhs1yqsrc%3D 9486961 (Pubitemid 28125269)
14. WE Sweeney Jr L Kusner CR Carlin S Chang L Futey CU Cotton KM Dell ED Avner 2001 Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKD Am J Physiol Cell Physiol 281 C1695 C1705 1:CAS:528:DC%2BD3MXos1ahsb4%3D 11600434 (Pubitemid 33121695)
15. F Park WE Sweeney Jr G Jia T Akbulut B Mueller JR Falck S Birudaraju RJ Roman ED Avner 2009 Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD Am J Physiol Renal Physiol 296 F575 F582 10.1152/ajprenal.90705.2008 1:CAS:528:DC%2BD1MXjtFGrsr0%3D 19129252
16. DJ Lager Q Qian RJ Bengal M Ishibashi VE Torres 2001 The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease Kidney Int 59 126 136 10.1046/j.1523-1755.2001.00473.x 1:STN:280:DC%2BD3M7jtFWktg%3D%3D 11135065 (Pubitemid 32055221)
17. LM Guay-Woodford RA Desmond 2003 Autosomal recessive polycystic kidney disease: the clinical experience in North America Pediatrics 111 1072 1080 10.1542/peds.111.5.1072 12728091 (Pubitemid 36542624)
18. K Zerres S Rudnik-Schoneborn F Deget U Holtkamp J Brodehl J Geisert K Scharer 1996 Autosomal recessive polycystic kidney disease in 115 children: clinical presentation, course and influence of gender Acta Paediatr 85 437 445 10.1111/j.1651-2227.1996.tb14056.x 1:STN:280:DyaK28zht1Ontw%3D%3D 8740301 (Pubitemid 26140265)
19. K Zerres S Rudnik-Schoneborn J Senderek T Eggermann C Bergmann 2003 Autosomal recessive polycystic kidney disease (ARPKD) J Nephrol 16 453 458 1:CAS:528:DC%2BD3sXmtVantrc%3D 12832752 (Pubitemid 36773200)
20. R Capisonda V Phan J Traubuci A Daneman JW Balfe LM Guay-Woodford 2003 Autosomal recessive polycystic kidney disease: outcomes from a single-center experience Pediatr Nephrol 18 119 126 12579400 (Pubitemid 41490298)
21. BS Kaplan J Fay V Shah MJ Dillon TM Barratt 1989 Autosomal recessive polycystic kidney disease Pediatr Nephrol 3 43 49 10.1007/BF00859625 1:STN:280:DyaK3M%2Fgt1WjsQ%3D%3D 2702087 (Pubitemid 19043592)
22. DS Keith VE Torres CM Johnson KE Holley 1994 Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats Am J Kidney Dis 24 491 498 1:CAS:528:DyaK2MXhvVWjtbg%3D 8079975
23. TM Kennefick MA Al-Nimri TT Oyama MM Thompson FJ Kelly JG Chapman S Anderson 1999 Hypertension and renal injury in experimental polycystic kidney disease Kidney Int 56 2181 2190 10.1046/j.1523-1755.1999.00783.x 1:CAS:528:DC%2BD3cXisVChtg%3D%3D 10594794 (Pubitemid 30004747)
24. I Zafar Y Tao S Falk K McFann RW Schrier CL Edelstein 2007 Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model Am J Physiol Renal Physiol 293 F854 F859 10.1152/ajprenal.00059.2007 1:CAS:528:DC%2BD2sXhtVOqt7nI 17581927 (Pubitemid 47403356)
25. AB Chapman PA Gabow 1997 Hypertension in autosomal dominant polycystic kidney disease Kidney Int Suppl 61 S71 S73 1:STN:280:DyaK2svmvFGjuw%3D%3D 9328971
26. AB Chapman A Johnson PA Gabow RW Schrier 1990 The renin-angiotensin- aldosterone system and autosomal dominant polycystic kidney disease N Engl J Med 323 1091 1096 1:STN:280:DyaK3M%2FhsFaiug%3D%3D 2215576 (Pubitemid 20370729)
27. A Masoumi B Reed-Gitomer C Kelleher MR Bekheirnia RW Schrier 2008 Developments in the management of autosomal dominant polycystic kidney disease Ther Clin Risk Manag 4 393 407 18728845 (Pubitemid 351711998)
28. JK Phillips D Hopwood RA Loxley K Ghatora JD Coombes YS Tan JL Harrison DJ McKitrick V Holobotvskyy LF Arnolda GK Rangan 2007 Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease Kidney Blood Press Res 30 129 144 10.1159/000101828 17446713 (Pubitemid 46976031)
29. M Hida S Omori M Awazu 2002 ERK and p38 MAP kinase are required for rat renal development Kidney Int 61 1252 1262 10.1046/j.1523-1755.2002.00273.x 1:CAS:528:DC%2BD38XjtVGqtro%3D 11918731 (Pubitemid 34304485)
30. S Omori M Hida H Fujita H Takahashi S Tanimura M Kohno M Awazu 2006 Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease J Am Soc Nephrol 17 1604 1614 10.1681/ASN.2004090800 1:CAS:528:DC%2BD28XlvVemurk%3D 16641154 (Pubitemid 43794663)
31. T Ecder VY Melnikov M Stanley D Korular MS Lucia RW Schrier CL Edelstein 2002 Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease Kidney Int 61 1220 1230 10.1046/j.1523-1755.2002.00250.x 1:CAS:528:DC%2BD38XjtVGqsbY%3D 11918728 (Pubitemid 34304482)
32. Y Tao J Kim S Faubel JC Wu SA Falk RW Schrier CL Edelstein 2005 Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease Proc Natl Acad Sci U S A 102 6954 6959 10.1073/pnas.0408518102 1:CAS:528:DC%2BD2MXksVKnsrs%3D 15863619 (Pubitemid 40675423)
33. Y Tao J Kim M Stanley Z He S Faubel RW Schrier CL Edelstein 2005 Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD) Kidney Int 67 909 919 10.1111/j.1523-1755.2005.00155.x 1:CAS:528:DC%2BD2MXis1Grtbs%3D 15698430 (Pubitemid 41623315)
34. Y Tao I Zafar J Kim RW Schrier CL Edelstein 2008 Caspase-3 gene deletion prolongs survival in polycystic kidney disease J Am Soc Nephrol 19 749 755 10.1681/ASN.2006121378 1:CAS:528:DC%2BD1cXkvFOhsbg%3D 18272845
35. BD Cowley Jr 2008 Calcium, cyclic AMP, and MAP kinases: dysregulation in polycystic kidney disease Kidney Int 73 251 253 10.1038/sj.ki.5002695 1:CAS:528:DC%2BD1cXmsVylsw%3D%3D 18195694
36. WC Earnshaw LM Martins SH Kaufmann 1999 Mammalian caspases: structure, activation, substrates, and functions during apoptosis Annu Rev Biochem 68 383 424 10.1146/annurev.biochem.68.1.383 1:CAS:528:DyaK1MXlvFajsb0%3D 10872455 (Pubitemid 29449198)
37. Y Shi 2002 Mechanisms of caspase activation and inhibition during apoptosis Mol Cell 9 459 470 10.1016/S1097-2765(02)00482-3 1:CAS:528: DC%2BD38XivVyltr0%3D 11931755 (Pubitemid 34273778)
38. BB Wolf DR Green 1999 Suicidal tendencies: apoptotic cell death by caspase family proteinases J Biol Chem 274 20049 20052 10.1074/jbc.274.29.20049 1:CAS:528:DyaK1MXks1Kqur0%3D 10400609 (Pubitemid 29340341)
39. DJ Veis CM Sorenson JR Shutter SJ Korsmeyer 1993 Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair Cell 75 229 240 10.1016/0092-8674(93)80065-M 1:CAS:528:DyaK3sXms1yisro%3D 8402909 (Pubitemid 23320287)
40. H Kaariainen O Koskimies R Norio 1988 Dominant and recessive polycystic kidney disease in children: evaluation of clinical features and laboratory data Pediatr Nephrol 2 296 302 10.1007/BF00858681 1:STN:280:DyaK3M%2Fgt1Snug%3D%3D 3153029 (Pubitemid 18001576)
41. AB Chapman LM Guay-Woodford JJ Grantham VE Torres KT Bae DA Baumgarten PJ Kenney BF King Jr JF Glockner LH Wetzel ME Brummer WC O'Neill ML Robbin WM Bennett S Klahr GH Hirschman PL Kimmel PA Thompson JP Miller 2003 Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort Kidney Int 64 1035 1045 10.1046/j.1523-1755.2003.00185.x 12911554 (Pubitemid 37013840)
42. AB Chapman AM Johnson PA Gabow RW Schrier 1994 Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease J Am Soc Nephrol 5 1349 1354 1:STN:280:DyaK2M3gtFahuw%3D%3D 7894001 (Pubitemid 24977120)
43. T Ecder CL Edelstein GM Fick-Brosnahan AM Johnson AB Chapman PA Gabow RW Schrier 2001 Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease Am J Nephrol 21 98 103 10.1159/000046231 1:STN:280:DC%2BD3M3mslKisQ%3D%3D 11359016 (Pubitemid 32453687)